AAME logo

Atlantic American (AAME) News & Sentiment

Atlantic American Corporation Reports Third Quarter Results for 2024
Atlantic American Corporation Reports Third Quarter Results for 2024
Atlantic American Corporation Reports Third Quarter Results for 2024
AAME
globenewswire.comNovember 12, 2024

ATLANTA, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Atlantic American Corporation (Nasdaq- AAME) today reported net loss of $2.0 million, or $(0.10) per diluted share, for the three month period ended September 30, 2024, compared to net income of $1.8 million, or $0.08 per diluted share, for the three month period ended September 30, 2023. The Company had net loss of $4.7 million, or $(0.24) per diluted share, for the nine month period ended September 30, 2024, compared to net income of $2.1 million, or $0.09 per diluted share, for the nine month period ended September 30, 2023. The increase in net loss for the three month and nine month periods ended September 30, 2024 was primarily the result of unfavorable loss experience in the Company's life and health operations due to an increase in incurred losses in the group life and Medicare supplement lines of business, as well as unfavorable loss experience in the Company's property and casualty operations due to the frequency and severity of claims in the automobile liability line of business, compared to the prior year periods.

Atlantic American Corporation Reports Second Quarter Results for 2024
Atlantic American Corporation Reports Second Quarter Results for 2024
Atlantic American Corporation Reports Second Quarter Results for 2024
AAME
globenewswire.comAugust 14, 2024

ATLANTA, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Atlantic American Corporation (Nasdaq- AAME) today reported net loss of $0.7 million, or $(0.04) per diluted share, for the three month period ended June 30, 2024, compared to net income of $1.7 million, or $0.08 per diluted share, for the three month period ended June 30, 2023. The Company had net loss of $2.7 million, or $(0.14) per diluted share, for the six month period ended June 30, 2024, compared to net income of $0.3 million, or $0.00 per diluted share, for the six month period ended June 30, 2023. The increase in net loss for the three month and six month periods ended June 30, 2024 was primarily the result of unfavorable loss experience in the Company's life and health operations, as well as in the Company's property and casualty operations, compared to the prior year periods.